BioMarin Pharmaceutical Inc. (BMRN) Financial Statements

Comprehensive financial analysis for BMRN including key ratios, revenue trends, profitability metrics, and analyst recommendations. Get detailed BMRN financial performance analysis and investment insights.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio (TTM):17.28

Forward P/E:10.75

EPS (TTM):$3.39

Enterprise Value:$10.32B

Profitability Ratios

Profit Margin:21.45%

Return on Equity:11.62%

Return on Assets:7.50%

Operating Margin:33.55%

Financial Health

Current Ratio:5.56

Quick Ratio:3.34

Debt to Equity:10.02

Beta (5Y):0.18

Revenue and Profit Trends

Growth Metrics

Revenue Growth

15.90%

Earnings Growth

124.30%

Revenue Per Share

$16.04

Performance Metrics

Profit Margin Trend

21.45%

Return on Equity

11.62%

Return on Assets

7.50%

Analyst Insights

Price Targets

Average Target

$97.62

High Target

$122.00

Low Target

$65.00

Analyst Recommendations

Recommendation

Buy

Analyst Coverage

26 Analysts

Upside Potential

+66.6%